Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Ebiomedicine|May 6, 2017
Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized MedicineLuigino Calzetta, Ermanno Puxeddu, Paola RoglianiCurrent Opinion in Pharmacology|February 19, 2018
Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPDJanis K Shute, Ermanno Puxeddu, Luigino CalzettaExpert Review of Respiratory Medicine|February 20, 2016
Olodaterol + tiotropium bromide for the treatment of COPDLuigino Calzetta, Chiara Ciaprini, Ermanno Puxeddu, et al.International Journal of Chronic Obstructive Pulmonary Disease|December 13, 2016
Airflow obstruction: is it asthma or is it COPD?Paola Rogliani, Josuel Ora, Ermanno Puxeddu, et al.Molecular Diagnosis & Therapy|August 1, 2019
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based BiomarkersMario Cazzola, Ermanno Puxeddu, Josuel Ora, et al.Expert Review of Respiratory Medicine|August 20, 2019
A potential role of triple therapy for asthma patientsMario Cazzola, Ermanno Puxeddu, Maria Gabriella Matera, et al.Expert Opinion on Pharmacotherapy|December 21, 2022
Expert guidance on the management and challenges of long-COVID syndrome: a systematic reviewJosuel Ora, Luigino Calzetta, Chiara Frugoni, et al.Frontiers in Molecular Biosciences|July 3, 2024
Role of exosomes in exacerbations of asthma and COPD: a systematic reviewRossella Laitano, Luigino Calzetta, Enrico Motta, et al.Respiratory Medicine|October 10, 2021
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic reviewPaola Rogliani, Beatrice Ludovica Ritondo, Ermanno Puxeddu, et al.Expert Opinion on Drug Safety|March 6, 2018
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPDMaria Gabriella Matera, Luigino Calzetta, Ermanno Puxeddu, et al.Pageof 5